These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience. Maric LS, Knezovic I, Papic N, Mise B, Roglic S, Markovinovic L, Tesovic G. Rheumatol Int; 2015 Jun; 35(6):1053-8. PubMed ID: 25429794 [Abstract] [Full Text] [Related]
30. Evaluation of clinical characteristics of Kawasaki syndrome and risk factors for coronary artery abnormalities among children in Denmark. Patel A, Holman RC, Callinan LS, Sreenivasan N, Schonberger LB, Fischer TK, Belay ED. Acta Paediatr; 2013 Apr; 102(4):385-90. PubMed ID: 23278838 [Abstract] [Full Text] [Related]
31. Persistent monocytosis after intravenous immunoglobulin therapy correlated with the development of coronary artery lesions in patients with Kawasaki disease. Kuo HC, Wang CL, Liang CD, Yu HR, Chen HH, Wang L, Yang KD. J Microbiol Immunol Infect; 2007 Oct; 40(5):395-400. PubMed ID: 17932598 [Abstract] [Full Text] [Related]
32. Hyponatremia Is a Feature of Kawasaki Disease Shock Syndrome: A Case-Control Study. Schuster JE, Palac HL, Innocentini N, Rowley AH, Young LT, Shulman ST. J Pediatric Infect Dis Soc; 2017 Nov 24; 6(4):386-388. PubMed ID: 28177492 [Abstract] [Full Text] [Related]
37. Prospective follow-up cardiac evaluation of children with Kawasaki disease in Northern India using the Japanese echocardiography criteria. Kothur K, Singh S, Sharma Y, Mittal BR. J Cardiol; 2007 Nov 24; 50(5):299-307. PubMed ID: 18044459 [Abstract] [Full Text] [Related]
38. Comparison of Characteristics and Outcomes of Multisystem Inflammatory Syndrome, Kawasaki Disease and Toxic Shock Syndrome in Children. Klavina L, Smane L, Kivite-Urtane A, Vasilevska L, Davidsone Z, Smitins E, Gardovska D, Lubaua I, Roge I, Pucuka Z, Meiere A, Pavare J. Medicina (Kaunas); 2023 Mar 21; 59(3):. PubMed ID: 36984627 [Abstract] [Full Text] [Related]